201 related articles for article (PubMed ID: 20739392)
1. Intrarenal suppression of angiotensin II type 1 receptor binding molecule in angiotensin II-infused mice.
Wakui H; Tamura K; Matsuda M; Bai Y; Dejima T; Shigenaga A; Masuda S; Azuma K; Maeda A; Hirose T; Ishigami T; Toya Y; Yabana M; Minamisawa S; Umemura S
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F991-F1003. PubMed ID: 20739392
[TBL] [Abstract][Full Text] [Related]
2. Renal tubule angiotensin II type 1 receptor-associated protein promotes natriuresis and inhibits salt-sensitive blood pressure elevation.
Wakui H; Uneda K; Tamura K; Ohsawa M; Azushima K; Kobayashi R; Ohki K; Dejima T; Kanaoka T; Tsurumi-Ikeya Y; Matsuda M; Haruhara K; Nishiyama A; Yabana M; Fujikawa T; Yamashita A; Umemura S
J Am Heart Assoc; 2015 Mar; 4(3):e001594. PubMed ID: 25792129
[TBL] [Abstract][Full Text] [Related]
3. Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats.
Dejima T; Tamura K; Wakui H; Maeda A; Ohsawa M; Kanaoka T; Haku S; Kengo A; Masuda S; Shigenaga A; Azuma K; Matsuda M; Yabana M; Hirose T; Uchino K; Kimura K; Nagashima Y; Umemura S
J Hypertens; 2011 Oct; 29(10):1919-29. PubMed ID: 21844822
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II type 1 receptor-associated protein prevents vascular smooth muscle cell senescence via inactivation of calcineurin/nuclear factor of activated T cells pathway.
Min LJ; Mogi M; Tamura K; Iwanami J; Sakata A; Fujita T; Tsukuda K; Jing F; Iwai M; Horiuchi M
J Mol Cell Cardiol; 2009 Dec; 47(6):798-809. PubMed ID: 19769983
[TBL] [Abstract][Full Text] [Related]
5. Expression of angiotensin II type 1 receptor-interacting molecule in normal human kidney and IgA nephropathy.
Masuda S; Tamura K; Wakui H; Maeda A; Dejima T; Hirose T; Toyoda M; Azuma K; Ohsawa M; Kanaoka T; Yanagi M; Yoshida S; Mitsuhashi H; Matsuda M; Ishigami T; Toya Y; Suzuki D; Nagashima Y; Umemura S
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F720-31. PubMed ID: 20685825
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II Type 1 Receptor Binding Molecule ATRAP as a Possible Modulator of Renal Sodium Handling and Blood Pressure in Pathophysiology.
Tamura K; Wakui H; Azushima K; Uneda K; Haku S; Kobayashi R; Ohki K; Haruhara K; Kinguchi S; Matsuda M; Yamashita A; Umemura S
Curr Med Chem; 2015; 22(28):3210-6. PubMed ID: 26295465
[TBL] [Abstract][Full Text] [Related]
7. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
Clayton JS; Clark KL; Johns EJ; Drew GM
Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II Type 1 Receptor-Associated Protein Regulates Kidney Aging and Lifespan Independent of Angiotensin.
Uneda K; Wakui H; Maeda A; Azushima K; Kobayashi R; Haku S; Ohki K; Haruhara K; Kinguchi S; Matsuda M; Ohsawa M; Minegishi S; Ishigami T; Toya Y; Atobe Y; Yamashita A; Umemura S; Tamura K
J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751545
[TBL] [Abstract][Full Text] [Related]
9. An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model.
Kobayashi R; Wakui H; Azushima K; Uneda K; Haku S; Ohki K; Haruhara K; Kinguchi S; Matsuda M; Ohsawa M; Toya Y; Nishiyama A; Yamashita A; Tanabe K; Maeshima Y; Umemura S; Tamura K
Kidney Int; 2017 May; 91(5):1115-1125. PubMed ID: 28081856
[TBL] [Abstract][Full Text] [Related]
10. The novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy.
Tanaka Y; Tamura K; Koide Y; Sakai M; Tsurumi Y; Noda Y; Umemura M; Ishigami T; Uchino K; Kimura K; Horiuchi M; Umemura S
FEBS Lett; 2005 Mar; 579(7):1579-86. PubMed ID: 15757644
[TBL] [Abstract][Full Text] [Related]
11. [Physiology of novel AT1 receptor-binding molecule, ATRAP].
Wakui H; Tamura K
Nihon Rinsho; 2012 Sep; 70(9):1499-503. PubMed ID: 23012794
[TBL] [Abstract][Full Text] [Related]
12. Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension.
Wakui H; Dejima T; Tamura K; Uneda K; Azuma K; Maeda A; Ohsawa M; Kanaoka T; Azushima K; Kobayashi R; Matsuda M; Yamashita A; Umemura S
Cardiovasc Res; 2013 Dec; 100(3):511-9. PubMed ID: 24189624
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type 1 receptor-associated protein deletion combined with angiotensin II stimulation accelerates the development of diabetic kidney disease in mice on a C57BL/6 strain.
Taguchi S; Azushima K; Yamaji T; Suzuki T; Abe E; Tanaka S; Hirota K; Tsukamoto S; Morita R; Kobayashi R; Kinguchi S; Yamashita A; Wakui H; Tamura K
Hypertens Res; 2024 Jan; 47(1):55-66. PubMed ID: 37957242
[TBL] [Abstract][Full Text] [Related]
14. Cardiac-specific activation of angiotensin II type 1 receptor-associated protein completely suppresses cardiac hypertrophy in chronic angiotensin II-infused mice.
Wakui H; Tamura K; Tanaka Y; Matsuda M; Bai Y; Dejima T; Masuda S; Shigenaga A; Maeda A; Mogi M; Ichihara N; Kobayashi Y; Hirawa N; Ishigami T; Toya Y; Yabana M; Horiuchi M; Minamisawa S; Umemura S
Hypertension; 2010 May; 55(5):1157-64. PubMed ID: 20231526
[TBL] [Abstract][Full Text] [Related]
15. Fetal uninephrectomy in male sheep alters the systemic and renal responses to angiotensin II infusion and AT1R blockade.
Singh RR; Moritz KM; Wintour EM; Jefferies AJ; Iqbal J; Bertram JF; Denton KM
Am J Physiol Renal Physiol; 2011 Aug; 301(2):F319-26. PubMed ID: 21543419
[TBL] [Abstract][Full Text] [Related]
16. Deletion of the angiotensin II type 1 receptor-associated protein enhances renal sodium reabsorption and exacerbates angiotensin II-mediated hypertension.
Ohsawa M; Tamura K; Wakui H; Maeda A; Dejima T; Kanaoka T; Azushima K; Uneda K; Tsurumi-Ikeya Y; Kobayashi R; Matsuda M; Uchida S; Toya Y; Kobori H; Nishiyama A; Yamashita A; Ishikawa Y; Umemura S
Kidney Int; 2014 Sep; 86(3):570-81. PubMed ID: 24694992
[TBL] [Abstract][Full Text] [Related]
17. Effects of ATRAP in Renal Proximal Tubules on Angiotensin-Dependent Hypertension.
Kinguchi S; Wakui H; Azushima K; Haruhara K; Koguchi T; Ohki K; Uneda K; Matsuda M; Haku S; Yamaji T; Yamada T; Kobayashi R; Minegishi S; Ishigami T; Yamashita A; Fujikawa T; Tamura K
J Am Heart Assoc; 2019 Apr; 8(8):e012395. PubMed ID: 30977419
[TBL] [Abstract][Full Text] [Related]
18. miR-125a-5p/miR-125b-5p contributes to pathological activation of angiotensin II-AT1R in mouse distal convoluted tubule cells by the suppression of Atrap.
Hirota K; Yamashita A; Abe E; Yamaji T; Azushima K; Tanaka S; Taguchi S; Tsukamoto S; Wakui H; Tamura K
J Biol Chem; 2023 Dec; 299(12):105478. PubMed ID: 37981211
[TBL] [Abstract][Full Text] [Related]
19. Effects of angiotensin II on insulin receptor binding and mRNA levels in normal and diabetic rats.
Sechi LA; Griffin CA; Zingaro L; Valentin JP; Bartoli E; Schambelan M
Diabetologia; 1997 Jul; 40(7):770-7. PubMed ID: 9243097
[TBL] [Abstract][Full Text] [Related]
20. The pathophysiological role of angiotensin receptor-binding protein in hypertension and kidney diseases: Oshima Award Address 2019.
Wakui H
Clin Exp Nephrol; 2020 Apr; 24(4):289-294. PubMed ID: 32112267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
